期刊文献+

含EB病毒LMP2A毕氏酵母表达载体的构建与表达LMP2A蛋白的检测 被引量:1

Expression of LMP2A Gene of Epstein-Barr Virus in Pichia pastoris
下载PDF
导出
摘要 目的:构建EB病毒潜伏膜蛋白2A的表达载体,并在真核生物毕氏酵母细胞中表达。方法:用EcoR I和Not I将含LMP2A全长编码基因的质粒PCIcc双酶切后,克隆到毕氏酵母载体PICZαA中,构建重组表达质粒pPICZαA-LMP2A。pICZαA-LMP2A经Sac I酶切线性化,采用氯化锂的方法转化毕氏酵母GS115,经YPD平板Zeocine抗性筛选获得LMP2A阳性克隆的菌株,用PCR鉴定阳性酵母转化子,并分别将阳性的酵母转化子在BMGY和BMMY培养基中进行诱导表达,表达产物进行SDS-PAGE电泳和western-blotting分析。结果:重组质粒pPICZαA-LMP2A经PCR和酶切鉴定为阳性。SDS-PAGE电泳和western-blotting结果显示表达蛋白的相对分子量为54 Kda,与预计值相同。结论:构建了LMP2A毕氏酵母表达载体,并在酵母细胞中成功表达。 Objective: To construct a recombinant plasmid pPICZαA-LMP2A for the expression of latent-infection membrane protein 2A(LMP2A) gene in Pichia pastoris. Methods: The plasmid pPCIcc containing the full length of LMP2A cDNA was digested with EcoR I and Not I and cloned into expression vector pPICZαA. The constructed plasmid pPICZαA-LMP2A was linarized with Sac I and transformed to Pichia pastoris GS115. The transformants were selected by planting cells on YPD/Zeocine plates, and then identified by PCR and expressed in BMGY and BMMY media. The expression product was analyzed by SDS-PAGE. Results: Based on the result of the 12% SDS-PAGE and western-blot, a recombinant protein about 53 KDa expressed in the yeast supernatant was identified to be recombinant LMP2A. Conclusion: The LMP2A cDNA successful expression was the foundation of further research in its fuction and constructed the suitable genetic engineering vaccine against EBV associated disease.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2004年第3期297-300,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助项目(N030170880) 江苏省"九五"攻关课题(BJ98100)
关键词 EB病毒 LMP2A基因 毕氏酵母 氯化锂 酵母细胞 肿瘤免疫疗法 Epstein-Barr Virus LMP2A gene Pichia pastoris expression
  • 相关文献

参考文献14

  • 1Young LS, Dawson CW, Eliopoulos AG. The expressin and function of Epstein-Barr virus encoded latent genes [J]. J Clin Pathol, 2000,53(5):238-247.
  • 2Delecluse HJ, Hammerschmidt W. The genetic approach to the Epstein-Barr virus: frombasic virology to gene therapy [J]. J Clin Pathol: Mol Pathol, 2000, 53(5):270-279.
  • 3Niedobitek G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma[J]. Mol Pathol,2000, 53(5):248-254.
  • 4Longneck R, Miller CL, Miao XQ, et al. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr Virus Latent Membrane Protein(LMP2A)are dispensable for lymphocyte infection and growth transformation in vitro[J]. J Virol, 1993,
  • 5Konishi K, Mamo S, Kato H. Role of Epstein-Barr vim-encoded latent membrane prgtein 2A on virus-induced immortalization and virus activation[J]. J Gene Virol, 2001,82(6):1451-1456.
  • 6Swanson-Mungerson M, Ikeda M, Lev L, et al. Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases[J]. J Antimicrob Chemother,2003, 52(2):152-154.
  • 7Portis T, Cooper L, Dennis P, et al. The LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease[J]. Front Biosci, 2002, 7:d414-426.
  • 8Scholle F, Longnecker R, Raab-Traub N. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phophorylation of the Epstein-Barr virus latent membrane protein2: a role for C-terminal src kinase[J]. J Virol,1999,73(6):4767-4775.
  • 9Scholle F, Longnecker R, Raab-Traub N. Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelialcells[J]. Virology, 2001; 291(2): 208-214.
  • 10Khanna R, Burrows SR. Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases[J] . Annu, Rev Microbiol, 2002,54(1):19-48.

二级参考文献14

共引文献5

同被引文献13

  • 1CHENYun,YAOKun,SUNHua,QINGJian,PENGGuang-yong.Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies[J].Chinese Medical Journal,2005(9):725-730. 被引量:1
  • 2Ingham RJ,Raaijmakers J,Lim CS,et al.The EpsteinBarr virus protein,latent membrane protein 2A,co-opts tyrosine kinases used by the T cell receptor[J].J Biol Chem,2005,280(40):34133-34142
  • 3Young LS,Dawson CW,Eliopoulos AG,et al.The expression and function of Epstein-Barr virus encoded latent genes[J].J Clin Pathol:Mol Pathol,2000,53(5):238-247
  • 4Longnecker R.Epstein-Barr virus latency:LMP2,a regulator or means for Epstein-Barr virus persistence[J]? Adv Cancer Res,2000,79:176-200
  • 5Straathof KC,Bollard CM,Popat U,et al.Treatment of nasopharyngeal carcinoma with Epstein-Barr virusspecific T lymphocytes[J].Blood,2005,105 (5):1898-1904
  • 6Baumforth KRN,Young LS,Flavell KL,et al.The Esptein-Barr virus and its association with human cancers[J].J Clin Pathol:Mol Pathol,2000,52(6):307-322
  • 7Yamashita N,Kimura H,Morishima T.Virological aspects of Epstein-Barr virus infections[J].Acta Med Okayama,2005,59(6):239-246
  • 8Niedobitek G.Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma[J].J Clin Pathol:Mol Pathol,2000,53 (5):248 -254
  • 9Young LS,Riekinson AB.Epstein-Barr virus:40 years on[J].Nat Rev Cancer,2004,4(10):757-768
  • 10Lopes V,Young LS,Murray PG.Epstein-Barr virusassociated cancers:aetiology and treatment[J].Herpes,2003,10(3):78-82

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部